BioSpace News Archive

Drug Development

Pfizer Inc. (JOBS) Discontinues A Phase 3 Study Of Figitumumab In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

March 12, 2010
·
5 min read
Business

Genetix Pharmaceuticals, Inc. Appoints Mitchell Finer, Ph.D. as Chief Scientific Officer

March 12, 2010
·
1 min read
Business

NeurogesX, Inc. to Hold Conference Call to Discuss Fourth Quarter and Year-End 2009 Results

March 12, 2010
·
2 min read
BioForest

Trubion Pharmaceuticals Inc. to Present Company Overview and Participate in Panel Discussion at Prestigious Life Science Innovation Northwest 2010

March 12, 2010
·
1 min read
Drug Development

Delcath Systems, Inc. Provides Update on Corporate Developments Data Release from Phase III Metastatic Melanoma Trial Still Expected in April FDA Submission Timeline Remains on Schedule

March 12, 2010
·
4 min read
Business

Halozyme Therapeutics, Inc. Reports Fourth Quarter and Year End 2009 Financial Results

March 12, 2010
·
4 min read
Drug Development

Tranzyme Pharma’s Clinical Results on Ulimorelin (TZP-101) Selected for Oral Presentation at the Distinguished Abstract Plenary Session of Digestive Disease Week 2010

March 12, 2010
·
1 min read
Genetown

Idera Pharmaceuticals, Inc. to Present an Overview of Toll-like Receptor Antagonist Program at 8th World Congress on Trauma, Shock, Inflammation and Sepsis

March 12, 2010
·
1 min read
Drug Development

Neoprobe Corporation Announces Successful Meeting on Lymphoseek Phase 3 Results

March 12, 2010
·
1 min read
Business

NPS Pharmaceuticals, Inc. Reports 2009 Results and 2010 Outlook

March 12, 2010
·
1 min read